LINCOLN PHARMACEUTICALS
Back to Income Statement
|
LINCOLN PHARMACEUTICALS Last 5 Year Profit Before Tax History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹122 Cr | ₹100 Cr | ₹96 Cr | ₹84 Cr | ₹67 Cr |
What is the latest Profit Before Tax of LINCOLN PHARMACEUTICALS ?
| Year | Profit Before Tax |
|---|---|
| Mar2025 | ₹122 Cr |
| Mar2024 | ₹100 Cr |
| Mar2023 | ₹96 Cr |
| Mar2022 | ₹84 Cr |
| Mar2021 | ₹67 Cr |
How is Profit Before Tax of LINCOLN PHARMACEUTICALS Trending?
| Years | Profit Before Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹122 Cr | 21.66 | |
| Mar2024 | ₹100 Cr | 4.73 | |
| Mar2023 | ₹96 Cr | 14.59 | |
| Mar2022 | ₹84 Cr | 24.52 | |
| Mar2021 | ₹67 Cr | - | |
Compare Profit Before Tax of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹900.0 Cr | -2.5% | -6.3% | -41.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹393,323.0 Cr | 1.7% | -5.7% | -7.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,825.0 Cr | 0.8% | -6.7% | 3.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,349.0 Cr | 0.6% | 4.3% | 24.4% | Stock Analytics | |
| CIPLA | ₹106,048.0 Cr | -4.7% | -12.3% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,494.0 Cr | 6.3% | -2.1% | -4.1% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | -2.5% |
-6.3% |
-41.3% |
| SENSEX | -1.7% |
-4.3% |
6.2% |
You may also like the below Video Courses